BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 17352741)

  • 1. c-Ski activates MyoD in the nucleus of myoblastic cells through suppression of histone deacetylases.
    Kobayashi N; Goto K; Horiguchi K; Nagata M; Kawata M; Miyazawa K; Saitoh M; Miyazono K
    Genes Cells; 2007 Mar; 12(3):375-85. PubMed ID: 17352741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear and cytoplasmic c-Ski differently modulate cellular functions.
    Nagata M; Goto K; Ehata S; Kobayashi N; Saitoh M; Miyoshi H; Imamura T; Miyazawa K; Miyazono K
    Genes Cells; 2006 Nov; 11(11):1267-80. PubMed ID: 17054724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation.
    Sun L; Liu L; Yang XJ; Wu Z
    J Cell Sci; 2004 Jun; 117(Pt 14):3021-9. PubMed ID: 15173318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin.
    Katagiri T; Akiyama S; Namiki M; Komaki M; Yamaguchi A; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T
    Exp Cell Res; 1997 Feb; 230(2):342-51. PubMed ID: 9024793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin initiates skeletal muscle differentiation by activating MEF2 and MyoD.
    Friday BB; Mitchell PO; Kegley KM; Pavlath GK
    Differentiation; 2003 Apr; 71(3):217-27. PubMed ID: 12694204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein.
    Johanson M; Meents H; Ragge K; Buchberger A; Arnold HH; Sandmöller A
    Biochem Biophys Res Commun; 1999 Nov; 265(1):222-32. PubMed ID: 10548518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements.
    Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K
    Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A treatment upregulates Id1 and Smad3 expression and delays skeletal muscle regeneration.
    Sakuma K; Nakao R; Aoi W; Inashima S; Fujikawa T; Hirata M; Sano M; Yasuhara M
    Acta Neuropathol; 2005 Sep; 110(3):269-80. PubMed ID: 15986223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor.
    Ferrand N; Atfi A; Prunier C
    Cancer Res; 2010 Nov; 70(21):8457-66. PubMed ID: 20959473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel functional co-operation between MyoD, MEF2 and TRalpha1 is sufficient for the induction of GLUT4 gene transcription.
    Santalucía T; Moreno H; Palacín M; Yacoub MH; Brand NJ; Zorzano A
    J Mol Biol; 2001 Nov; 314(2):195-204. PubMed ID: 11718554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of c-fos promoter by MyoD on muscle cell differentiation.
    Trouche D; Grigoriev M; Lenormand JL; Robin P; Leibovitch SA; Sassone-Corsi P; Harel-Bellan A
    Nature; 1993 May; 363(6424):79-82. PubMed ID: 8386804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mirk/dyrk1B decreases the nuclear accumulation of class II histone deacetylases during skeletal muscle differentiation.
    Deng X; Ewton DZ; Mercer SE; Friedman E
    J Biol Chem; 2005 Feb; 280(6):4894-905. PubMed ID: 15546868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle-specific transcription factors in fibroblasts expressing the alpha-striated tropomyosin 3' untranslated region.
    L'ecuyer TJ; Schutte BC; Mendel KA; Morris E; Fulton AB
    Mol Genet Metab; 1999 Jul; 67(3):213-26. PubMed ID: 10381329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway.
    Meissner JD; Umeda PK; Chang KC; Gros G; Scheibe RJ
    J Cell Physiol; 2007 Apr; 211(1):138-48. PubMed ID: 17111365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RhoA effector mDiaphanous regulates MyoD expression and cell cycle progression via SRF-dependent and SRF-independent pathways.
    Gopinath SD; Narumiya S; Dhawan J
    J Cell Sci; 2007 Sep; 120(Pt 17):3086-98. PubMed ID: 17684061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The homeobox gene Arx is a novel positive regulator of embryonic myogenesis.
    Biressi S; Messina G; Collombat P; Tagliafico E; Monteverde S; Benedetti L; Cusella De Angelis MG; Mansouri A; Ferrari S; Tajbakhsh S; Broccoli V; Cossu G
    Cell Death Differ; 2008 Jan; 15(1):94-104. PubMed ID: 17932502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Myb inhibits myogenic differentiation through repression of MyoD.
    Kaspar P; Pajer P; Sedlak D; Tamaoki T; Dvorak M
    Exp Cell Res; 2005 Oct; 309(2):419-28. PubMed ID: 16055116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of mouse c-ski accompanies terminal skeletal muscle differentiation in vivo and in vitro.
    Namciu S; Lyons GE; Micales BK; Heyman HC; Colmenares C; Stavnezer E
    Dev Dyn; 1995 Nov; 204(3):291-300. PubMed ID: 8573720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of HDAC9 gene expression by MEF2 establishes a negative-feedback loop in the transcriptional circuitry of muscle differentiation.
    Haberland M; Arnold MA; McAnally J; Phan D; Kim Y; Olson EN
    Mol Cell Biol; 2007 Jan; 27(2):518-25. PubMed ID: 17101791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM72, a novel negative feedback regulator of myogenesis, is transcriptionally activated by the synergism of MyoD (or myogenin) and MEF2.
    Jung SY; Ko YG
    Biochem Biophys Res Commun; 2010 May; 396(2):238-45. PubMed ID: 20399744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.